Products
Online Inquiry
Drp1 peptide inhibitor P110 (Compound P110) is a selective, neuroprotective Drp1 peptide inhibitor. It prevents MPTP-induced Drp1 mitochondrial translocation, reducing dopaminergic neuron loss, nerve terminal damage, and behavioral deficits, making it useful for Alzheimer’s disease research.
Formula | C100H179N45O25 |
---|---|
Molecular Weight | 2411.78 |
Biological Target | Dynamin |
Research Areas | Cardiovascular Disease, Neurological Disease |
Sequence | Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Gly-Gly-Asp-Leu-Leu-Pro-Arg-Gly-Ser-NH2 |
Sequence Shortening | YGRKKRRQRRRGGDLLPRGS-NH2 |
Shipping Conditions | Room Temperature |
Storage Information | Powder: -80°C (2 years), -20°C (1 year); In solvent: -80°C (6 months), -20°C (1 month) |